CLINICAL AND PATHOGENETIC JUSTIFICATION OF THE EFFECTIVENESS OF COMBINED THERAPY WITH FINERENONE AND SGLT2 INHIBITORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Mamadjаnov S.K.

2026-02-12 13:19:20 Back